Vitamin D status and intermediate vascular and bone outcomes in chronic kidney disease: a secondary <i>post hoc</i> analysis of <scp>IMPROVE‐CKD</scp>
Baseline 25(OH)D levels were not associated with intermediate markers of vascular function and BMD in patients with CKD stages 3b and 4.
Authors
- Elaine M. Pascoe (ORCID: https://orcid.org/0000-0003-1653-5803)
- Grahame J. Elder (ORCID: https://orcid.org/0000-0001-5685-4636)
- Nicole Lioufas (ORCID: https://orcid.org/0000-0002-3936-0551)
- Wing‐Chi G. Yeung (ORCID: https://orcid.org/0000-0002-3387-3743)
- Nigel D. Toussaint (ORCID: https://orcid.org/0000-0002-2853-5096)
- Andrea Valks
- Sunil V. Badve (ORCID: https://orcid.org/0000-0003-2269-312X)
- Carmel M. Hawley (ORCID: https://orcid.org/0000-0002-1392-5649)
Institutions
- Translational Research Institute (AU)
- The Royal Melbourne Hospital (AU)
- Garvan Institute of Medical Research (AU)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Wollongong Hospital (AU)
- Princess Alexandra Hospital (AU)
- Westmead Hospital (AU)
- UNSW Sydney (AU)
- The George Institute for Global Health (AU)
- St George Hospital (AU)
- Kidney Health Australia (AU)
- The University of Notre Dame Australia (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1111/imj.16516
- Citations
- 5
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.12
Funders
- University of New South Wales